Orchestrating cell cycle arrest and innate immune sensing for synergistic radiotherapy and immunotherapy against non-small cell lung cancer
Authors: You, Lukuan; Chen, Zhuang; Bei, Jiayi; Cui, Can; Xu, Yinmei; Fu, Yankan; Ren, Yifan; Chen, Bo; Wang, Zhongliang; Li, Jianxiong
Source journal: Journal of nanobiotechnology (2026-08-26)
DOI: 10.1186/s12951-026-04980-4
Abstract
Radiotherapy combined with immunotherapy is a pivotal strategy for non-small cell lung cancer; yet, its efficacy is severely compromised by tumor heterogeneity and insufficient innate immune activation. Herein, a tumor microenvironment responsive GSK@BSA-MnO(2) nanoplatform is engineered to spatiotemporally synchronize cell cycle arrest with cGAS-STING activation. Upon glutathione triggered degradation, the nanoplatform releases the PLK1 inhibitor GSK461364 and Mn(2)(+) ions. Mechanistically, GSK461364 enforces G2/M arrest, profoundly amplifying radiation-induced DNA damage and immunogenic cell death. Crucially, this enriched cytosolic DNA pool is concurrently sensed by cGAS-STING pathway, which is vigorously sensitized by the Mn(2)(+) generated locally, culminating in robust type I interferon secretion. This synergistic modulation effectively remodels the immunosuppressive microenvironment, increases CD8(+) T cell infiltration and induces a strong abscopal effect against metastatic lesions. Collectively, combining cell cycle arrest with innate immune activation is a promising strategy to improve the efficacy of radio-immunotherapy.
Related topics
Related open access articles
- A simple and effective fluorescent and colorimetric probe for the detection of glutathione in human serum
- Alleviating Effects of Ascorbic acid and Glutathione for Faba Bean Plants Irrigated with Saline Water.
- Alleviating Effects of Ascorbic acid and Glutathione for Faba Bean Plants Irrigated with Saline Water
- A Brief Review on Core/shell Quantum Dots
- Biochemical changes in sunflower plant exposed to silver nanoparticles / silver ions
- In vitro cytotoxicity studies on galactosylated chitosan nanoparticles for the delivery of oridonin to liver
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.